SGS
EXAS

Sterling Global Strategies’s Exact Sciences EXAS Stock Holding History

Sterling Global Strategies’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-225
Closed -$14.2K – 78
2018
Q4 		$14.2K Buy
+225
New +$15.4K 0.07% 133

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Sterling Global Strategies's EXAS Position: Q1 2019 in Review

Sterling Global Strategies sold out of Exact Sciences (EXAS) in Q1 2019, closing a stake of 225 shares — an estimated $14.2K sold.

Sterling Global Strategies first reported a position in EXAS in Q4 2018 and held it in 1 quarter. The position peaked at $14.2K in Q4 2018. 423 funds tracked by Wall St. Rank hold EXAS as of Q1 2019.

  • Sterling Global Strategies reported no remaining Exact Sciences position as of Q1 2019 after selling out during the quarter.
  • Sterling Global Strategies sold 225 Exact Sciences shares in Q1 2019, an estimated $14.2K.
  • Sterling Global Strategies first reported a position in Exact Sciences in Q4 2018 and held it in 1 quarter.
  • Sterling Global Strategies's Exact Sciences position peaked at $14.2K in Q4 2018.
  • 423 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2019.

Based on Sterling Global Strategies's 13F filing for Q1 2019, filed 15 May 2019.